Page 15 - Secondary Progressive Multiple Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tiziana Life Sciences Announces An Interview on Clinical

NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling.

United statesKunwar shailubhaiHana malikTiziana life sciencesTiziana life sciences nasdaqTiziana life sciences ltdBusiness developmentLife sciencesChief executive officerChief scientific officer kunwar shailubhaiProactive investorsSecondary progressive multiple sclerosisInvestor relations managerNasdaq tlsaTiziana life sciences plc

Tiziana Life Sciences Ltd : Tiziana Life Sciences Announces An Interview on Clinical Improvements for 2nd SPMS Patient

NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug administration

United statesKunwar shailubhaiHana malikTiziana life sciencesTiziana life sciences nasdaqTiziana life sciences ltdBusiness developmentLife sciencesChief executive officerChief scientific officer kunwar shailubhaiProactive investorsSecondary progressive multiple sclerosisInvestor relations

Tiziana Life Sciences Ltd : Tiziana Life Sciences Announces Positive Clinical Results in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) Following Three Months of Dosing with Intranasal Foralumab

A second patient also showed clinical improvements in the Positron Emission Tomography (PET) imaging analysis, neurologic exam, and in the Timed 25-Foot Walk test, following three months of treatment.

United statesKunwar shailubhaiIrina kofflerHana malikHoward weinerTanuja chitnisTarun singhalLifesci advisorsDrug administrationTiziana life sciencesImaging program in neurologic diseasesProfessor of neurology at harvard medical schoolTiziana life sciences nasdaqTiziana life sciences ltdBusiness developmentAccess program

Tiziana Life Sciences Announces Positive Clinical Results in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) Following Three Months of Dosing with Intranasal Foralumab

Tiziana Life Sciences Announces Positive Clinical Results in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) Following Three Months of Dosing with Intranasal Foralumab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKunwar shailubhaiIrina kofflerHana malikHoward weinerTanuja chitnisTarun singhalLifesci advisorsDrug administrationTiziana life sciencesImaging program in neurologic diseasesProfessor of neurology at harvard medical schoolTiziana life sciences nasdaqTiziana life sciences ltdBusiness developmentAccess program

Tiziana Life Sciences PLC reports positive results from second patient in secondary progressive multiple sclerosis study of foralumab

Tiziana Life Sciences PLC reports positive results from second patient in secondary progressive multiple sclerosis study of foralumab
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesKunwar shailubhaiTarun singhalTiziana life sciencesImaging program in neurologic diseasesDrug administrationSecondary progressive multiple sclerosisPositron emission tomographyNeurologic diseasesLife sciences